Oncology Journal Issues Research Articles in November 2022 Edition
November 17, 2022
November 17, 2022
CHICAGO, Illinois, Nov. 17 -- JAMA Oncology, an international peer-reviewed journal for scientists, clinicians and trainees in the field of oncology from the American Medical Association, published research articles on the following topics in its November 2022 edition:
Original Investigations:
* Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial
* Constitutional BRCA1 Methylation and Risk . . .
Original Investigations:
* Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial
* Constitutional BRCA1 Methylation and Risk . . .